speb/financial-data huggingface dataset:
MDA.TO balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 390900000.00
MDA.TO balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 390900000.00
MDA.TO cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 645000000.00
MDA.TO cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: 315000000.00
MDA.TO cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -478400000.00
MDA.TO cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -328100000.00
MDA.TO balance_sheet (annual, 2025-12-31) — Long Term Equity Investment: 11300000.00
MDA.TO balance_sheet (quarterly, 2025-12-31) — Long Term Equity Investment: 11300000.00
MDA.TO balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 52200000.00
MDA.TO balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 52200000.00
MDA.TO cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: -372600000.00
MDA.TO cash_flow (quarterly, 2025-12-31) — Net Business Purchase And Sale: -10000000.00
MDA.TO balance_sheet (annual, 2025-12-31) — Net Debt: 120000000.00
MDA.TO balance_sheet (quarterly, 2025-12-31) — Net Debt: 120000000.00
MDA.TO income_statement (annual, 2025-12-31) — Net Income: 108500000.00
MDA.TO income_statement (quarterly, 2025-12-31) — Net Income: 24000000.00
MDA.TO income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 108500000.00
MDA.TO income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 24000000.00
MDA.TO income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 108500000.00
MDA.TO income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 24000000.00
MDA.TO income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 108500000.00
MDA.TO income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 24000000.00
MDA.TO income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 108500000.00
MDA.TO income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 24000000.00
MDA.TO cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 108500000.00
MDA.TO cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 24000000.00
MDA.TO income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 108500000.00
MDA.TO income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 24000000.00
MDA.TO cash_flow (annual, 2025-12-31) — Net Intangibles Purchase And Sale: -100100000.00
MDA.TO cash_flow (quarterly, 2025-12-31) — Net Intangibles Purchase And Sale: -35600000.00
MDA.TO income_statement (annual, 2025-12-31) — Net Interest Income: -9200000.00
MDA.TO income_statement (quarterly, 2025-12-31) — Net Interest Income: -2900000.00
MDA.TO cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: 166600000.00
MDA.TO cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -13100000.00
MDA.TO cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: 166600000.00
MDA.TO cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -13100000.00
MDA.TO income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -9200000.00
MDA.TO income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -2900000.00
MDA.TO cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -8300000.00
MDA.TO cash_flow (annual, 2025-12-31) — Net Other Investing Changes: 33400000.00
MDA.TO cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: 0.00
MDA.TO balance_sheet (annual, 2025-12-31) — Net PPE: 764100000.00
MDA.TO balance_sheet (quarterly, 2025-12-31) — Net PPE: 764100000.00
MDA.TO cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -175300000.00
MDA.TO cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -38800000.00
MDA.TO balance_sheet (annual, 2025-12-31) — Net Tangible Assets: -322100000.00
MDA.TO balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: -322100000.00
MDA.TO balance_sheet (annual, 2025-12-31) — Non Current Deferred Assets: 10000000.00
MDA.TO balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Assets: 10000000.00
MDA.TO balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 245700000.00
MDA.TO balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 245700000.00
MDA.TO balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Assets: 10000000.00
MDA.TO balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Assets: 10000000.00
MDA.TO balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 245700000.00
MDA.TO balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 245700000.00
MDA.TO income_statement (annual, 2025-12-31) — Normalized EBITDA: 307200000.00
MDA.TO income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 92800000.00
MDA.TO income_statement (annual, 2025-12-31) — Normalized Income: 106506561.68
MDA.TO income_statement (quarterly, 2025-12-31) — Normalized Income: 31680000.00
MDA.TO cash_flow (annual, 2025-12-31) — Operating Cash Flow: 407500000.00
MDA.TO cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 54900000.00
MDA.TO income_statement (annual, 2025-12-31) — Operating Income: 157800000.00
MDA.TO income_statement (quarterly, 2025-12-31) — Operating Income: 45800000.00
MDA.TO income_statement (annual, 2025-12-31) — Operating Revenue: 1633200000.00
MDA.TO income_statement (quarterly, 2025-12-31) — Operating Revenue: 499100000.00
MDA.TO balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 126321001.00
MDA.TO balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 126321001.00
MDA.TO balance_sheet (annual, 2025-12-31) — Other Current Assets: 53300000.00
MDA.TO balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 53300000.00
MDA.TO balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 19200000.00
MDA.TO balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 19200000.00
MDA.TO balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: 29100000.00
MDA.TO balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: 29100000.00
MDA.TO income_statement (annual, 2025-12-31) — Other Gand A: 65100000.00
MDA.TO income_statement (quarterly, 2025-12-31) — Other Gand A: 20100000.00
MDA.TO income_statement (annual, 2025-12-31) — Other Income Expense: 3800000.00
MDA.TO income_statement (quarterly, 2025-12-31) — Other Income Expense: -10400000.00
MDA.TO balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 876700000.00
MDA.TO balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 876700000.00
MDA.TO cash_flow (annual, 2025-12-31) — Other Non Cash Items: 9200000.00
MDA.TO cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 2900000.00
MDA.TO balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 279200000.00
MDA.TO balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 279200000.00
MDA.TO balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 23400000.00
MDA.TO balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 23400000.00
MDA.TO income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: 1000000.00
MDA.TO income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 0.00
MDA.TO balance_sheet (annual, 2025-12-31) — Other Payable: 77100000.00
MDA.TO balance_sheet (quarterly, 2025-12-31) — Other Payable: 77100000.00
MDA.TO balance_sheet (annual, 2025-12-31) — Other Properties: 78100000.00
MDA.TO balance_sheet (quarterly, 2025-12-31) — Other Properties: 78100000.00
MDA.TO balance_sheet (annual, 2025-12-31) — Other Receivables: 250700000.00
MDA.TO balance_sheet (quarterly, 2025-12-31) — Other Receivables: 250700000.00
MDA.TO balance_sheet (annual, 2025-12-31) — Payables: 479500000.00
MDA.TO balance_sheet (quarterly, 2025-12-31) — Payables: 479500000.00
MDA.TO balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 479500000.00
MDA.TO balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 479500000.00
MDA.TO income_statement (annual, 2025-12-31) — Pretax Income: 152400000.00
MDA.TO income_statement (quarterly, 2025-12-31) — Pretax Income: 32500000.00
MDA.TO cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 38000000.00
MDA.TO cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 500000.00
MDA.TO balance_sheet (annual, 2025-12-31) — Properties: 0.00
MDA.TO balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
MDA.TO cash_flow (annual, 2025-12-31) — Purchase Of Business: -372600000.00
MDA.TO cash_flow (quarterly, 2025-12-31) — Purchase Of Business: -10000000.00
MDA.TO cash_flow (annual, 2025-12-31) — Purchase Of Intangibles: -100100000.00
MDA.TO cash_flow (quarterly, 2025-12-31) — Purchase Of Intangibles: -35600000.00
MDA.TO cash_flow (annual, 2025-12-31) — Purchase Of PPE: -175300000.00
MDA.TO cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -38800000.00
MDA.TO balance_sheet (annual, 2025-12-31) — Raw Materials: 15700000.00
MDA.TO balance_sheet (quarterly, 2025-12-31) — Raw Materials: 15700000.00
MDA.TO balance_sheet (annual, 2025-12-31) — Receivables: 385700000.00
MDA.TO balance_sheet (quarterly, 2025-12-31) — Receivables: 385700000.00
MDA.TO balance_sheet (annual, 2025-12-31) — Receivables Adjustments Allowances: -3400000.00
MDA.TO balance_sheet (quarterly, 2025-12-31) — Receivables Adjustments Allowances: -3400000.00
MDA.TO income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 1167500000.00
MDA.TO income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 357000000.00
MDA.TO income_statement (annual, 2025-12-31) — Reconciled Depreciation: 140600000.00
MDA.TO income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 46300000.00
MDA.TO cash_flow (annual, 2025-12-31) — Repayment Of Debt: -478400000.00
MDA.TO cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -328100000.00
MDA.TO income_statement (annual, 2025-12-31) — Research And Development: 38100000.00
MDA.TO income_statement (quarterly, 2025-12-31) — Research And Development: 14700000.00
MDA.TO balance_sheet (annual, 2025-12-31) — Retained Earnings: 247200000.00
MDA.TO balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 247200000.00
MDA.TO income_statement (annual, 2025-12-31) — Salaries And Wages: 17700000.00
MDA.TO income_statement (quarterly, 2025-12-31) — Salaries And Wages: 4800000.00
MDA.TO income_statement (annual, 2025-12-31) — Selling And Marketing Expense: 46400000.00
MDA.TO income_statement (quarterly, 2025-12-31) — Selling And Marketing Expense: 10400000.00
MDA.TO income_statement (annual, 2025-12-31) — Selling General And Administration: 129200000.00
MDA.TO income_statement (quarterly, 2025-12-31) — Selling General And Administration: 35300000.00
MDA.TO balance_sheet (annual, 2025-12-31) — Share Issued: 126321001.00
MDA.TO balance_sheet (quarterly, 2025-12-31) — Share Issued: 126321001.00
MDA.TO cash_flow (annual, 2025-12-31) — Stock Based Compensation: 12800000.00
MDA.TO cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 3500000.00
MDA.TO balance_sheet (annual, 2025-12-31) — Stockholders Equity: 1355000000.00
MDA.TO balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 1355000000.00
MDA.TO balance_sheet (annual, 2025-12-31) — Tangible Book Value: -322100000.00
MDA.TO balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: -322100000.00
MDA.TO income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 806561.68
MDA.TO income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -2720000.00
MDA.TO income_statement (annual, 2025-12-31) — Tax Provision: 43900000.00
MDA.TO income_statement (quarterly, 2025-12-31) — Tax Provision: 8500000.00
MDA.TO income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.29
MDA.TO income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.26
MDA.TO balance_sheet (annual, 2025-12-31) — Taxes Receivable: 52900000.00
MDA.TO balance_sheet (quarterly, 2025-12-31) — Taxes Receivable: 52900000.00
MDA.TO cash_flow (annual, 2025-12-31) — Taxes Refund Paid: 4300000.00
MDA.TO cash_flow (quarterly, 2025-12-31) — Taxes Refund Paid: -3600000.00
MDA.TO balance_sheet (annual, 2025-12-31) — Total Assets: 3356200000.00
MDA.TO balance_sheet (quarterly, 2025-12-31) — Total Assets: 3356200000.00
MDA.TO balance_sheet (annual, 2025-12-31) — Total Capitalization: 1627000000.00
MDA.TO balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 1627000000.00
MDA.TO balance_sheet (annual, 2025-12-31) — Total Debt: 411100000.00
MDA.TO balance_sheet (quarterly, 2025-12-31) — Total Debt: 411100000.00
MDA.TO balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 1355000000.00
MDA.TO balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 1355000000.00
MDA.TO income_statement (annual, 2025-12-31) — Total Expenses: 1475400000.00
MDA.TO income_statement (quarterly, 2025-12-31) — Total Expenses: 453300000.00
MDA.TO balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 2001200000.00
MDA.TO balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 2001200000.00
MDA.TO balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 2741700000.00
MDA.TO balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 2741700000.00
MDA.TO balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 683400000.00
MDA.TO balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 683400000.00
MDA.TO income_statement (annual, 2025-12-31) — Total Operating Income As Reported: 157800000.00
MDA.TO income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: 45800000.00
MDA.TO balance_sheet (annual, 2025-12-31) — Total Tax Payable: 11000000.00
MDA.TO balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 11000000.00
MDA.TO income_statement (annual, 2025-12-31) — Total Unusual Items: 2800000.00
MDA.TO income_statement (quarterly, 2025-12-31) — Total Unusual Items: -10400000.00
MDA.TO income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: 2800000.00
MDA.TO income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -10400000.00
MDA.TO balance_sheet (annual, 2025-12-31) — Tradeand Other Payables Non Current: 23400000.00
MDA.TO balance_sheet (quarterly, 2025-12-31) — Tradeand Other Payables Non Current: 23400000.00
MDA.TO balance_sheet (annual, 2025-12-31) — Treasury Shares Number: 0.00
MDA.TO balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 0.00
MDA.TO cash_flow (annual, 2025-12-31) — Unrealized Gain Loss On Investment Securities: -5000000.00
MDA.TO cash_flow (quarterly, 2025-12-31) — Unrealized Gain Loss On Investment Securities: -7000000.00
MDA.TO balance_sheet (annual, 2025-12-31) — Work In Process: 6400000.00
MDA.TO balance_sheet (quarterly, 2025-12-31) — Work In Process: 6400000.00
MDA.TO balance_sheet (annual, 2025-12-31) — Working Capital: -703300000.00
MDA.TO balance_sheet (quarterly, 2025-12-31) — Working Capital: -703300000.00
MDA.TO income_statement (quarterly, 2026-03-31) — +Operating Expense: 75100000.00
MDA.TO income_statement (quarterly, 2026-03-31) — +Total Revenue: 464100000.00
MDA.TO balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 458600000.00
MDA.TO balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 149000000.00
MDA.TO balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -93500000.00
MDA.TO balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 37900000.00
MDA.TO income_statement (quarterly, 2026-03-31) — Amortization: 30500000.00
MDA.TO cash_flow (quarterly, 2026-03-31) — Amortization Cash Flow: 33800000.00
MDA.TO cash_flow (quarterly, 2026-03-31) — Amortization Of Intangibles: 33800000.00
MDA.TO income_statement (quarterly, 2026-03-31) — Amortization Of Intangibles Income Statement: 30500000.00
MDA.TO income_statement (quarterly, 2026-03-31) — Basic Average Shares: 138659395.00
MDA.TO income_statement (quarterly, 2026-03-31) — Basic EPS: 0.21
MDA.TO cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 152000000.00
MDA.TO balance_sheet (quarterly, 2026-03-31) — Buildings And Improvements: 109300000.00
MDA.TO cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -88500000.00
MDA.TO balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 136000000.00
MDA.TO balance_sheet (quarterly, 2026-03-31) — Capital Stock: 1501900000.00
MDA.TO balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 544000000.00
MDA.TO balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 544000000.00
MDA.TO balance_sheet (quarterly, 2026-03-31) — Cash Financial: 544000000.00
MDA.TO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 411400000.00
MDA.TO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -79100000.00
MDA.TO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 60900000.00
MDA.TO cash_flow (quarterly, 2026-03-31) — Change In Inventory: -13500000.00
MDA.TO cash_flow (quarterly, 2026-03-31) — Change In Other Current Assets: 3000000.00
MDA.TO cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: -3600000.00
MDA.TO cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: -77200000.00
MDA.TO cash_flow (quarterly, 2026-03-31) — Change In Payable: 96600000.00
MDA.TO cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: 96600000.00
MDA.TO cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: -2900000.00
MDA.TO cash_flow (quarterly, 2026-03-31) — Change In Receivables: -23800000.00
MDA.TO cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -21400000.00
MDA.TO cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: 100000.00
MDA.TO cash_flow (quarterly, 2026-03-31) — Changes In Cash: 393200000.00
MDA.TO balance_sheet (quarterly, 2026-03-31) — Common Stock: 1501900000.00
MDA.TO balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 1846700000.00
MDA.TO cash_flow (quarterly, 2026-03-31) — Common Stock Issuance: 441500000.00
MDA.TO balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 385300000.00
MDA.TO income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 348900000.00
MDA.TO balance_sheet (quarterly, 2026-03-31) — Current Assets: 1040500000.00
MDA.TO balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 19800000.00
MDA.TO balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 19800000.00
MDA.TO balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 710700000.00
MDA.TO balance_sheet (quarterly, 2026-03-31) — Current Deferred Revenue: 710700000.00
MDA.TO balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 1308500000.00
MDA.TO cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: 1000000.00
MDA.TO cash_flow (quarterly, 2026-03-31) — Deferred Tax: 1000000.00
MDA.TO cash_flow (quarterly, 2026-03-31) — Depreciation: 12400000.00
MDA.TO cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 46200000.00
MDA.TO income_statement (quarterly, 2026-03-31) — Depreciation Amortization Depletion Income Statement: 30500000.00
MDA.TO cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 46200000.00
MDA.TO income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 30500000.00
MDA.TO income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 138659395.00
MDA.TO income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.21
MDA.TO income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 29600000.00
MDA.TO income_statement (quarterly, 2026-03-31) — EBIT: 47600000.00
MDA.TO income_statement (quarterly, 2026-03-31) — EBITDA: 78100000.00
MDA.TO income_statement (quarterly, 2026-03-31) — Earnings From Equity Interest: -1500000.00
MDA.TO cash_flow (quarterly, 2026-03-31) — Earnings Losses From Equity Investments: 1500000.00
MDA.TO cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: -3900000.00
MDA.TO cash_flow (quarterly, 2026-03-31) — End Cash Position: 544000000.00
MDA.TO cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 411400000.00
MDA.TO balance_sheet (quarterly, 2026-03-31) — Finished Goods: 3700000.00
MDA.TO cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -27600000.00
MDA.TO cash_flow (quarterly, 2026-03-31) — Gain Loss On Investment Securities: 400000.00
MDA.TO income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: 8000000.00
MDA.TO balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: 30100000.00
MDA.TO income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 24200000.00
MDA.TO balance_sheet (quarterly, 2026-03-31) — Goodwill: 804900000.00
MDA.TO balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 1677600000.00
MDA.TO balance_sheet (quarterly, 2026-03-31) — Gross PPE: 870600000.00
MDA.TO income_statement (quarterly, 2026-03-31) — Gross Profit: 115200000.00
MDA.TO balance_sheet (quarterly, 2026-03-31) — Income Tax Payable: 12800000.00
MDA.TO income_statement (quarterly, 2026-03-31) — Interest Expense: 6400000.00
MDA.TO income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 6400000.00
MDA.TO income_statement (quarterly, 2026-03-31) — Interest Income: 1000000.00
MDA.TO income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 1000000.00
MDA.TO cash_flow (quarterly, 2026-03-31) — Interest Paid Cfo: -2300000.00
MDA.TO balance_sheet (quarterly, 2026-03-31) — Inventories Adjustments Allowances: -1000000.00
MDA.TO balance_sheet (quarterly, 2026-03-31) — Inventory: 37000000.00
MDA.TO balance_sheet (quarterly, 2026-03-31) — Invested Capital: 2091400000.00
MDA.TO cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -79100000.00
MDA.TO balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 9800000.00
MDA.TO cash_flow (quarterly, 2026-03-31) — Issuance Of Capital Stock: 441500000.00
MDA.TO cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 95000000.00
MDA.TO balance_sheet (quarterly, 2026-03-31) — Land And Improvements: 218500000.00
MDA.TO balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 116200000.00
MDA.TO balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 244700000.00
MDA.TO balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 360900000.00
MDA.TO cash_flow (quarterly, 2026-03-31) — Long Term Debt Issuance: 95000000.00
MDA.TO cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -128000000.00
MDA.TO balance_sheet (quarterly, 2026-03-31) — Long Term Equity Investment: 9800000.00
MDA.TO balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 56800000.00
MDA.TO cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: 441500000.00
MDA.TO income_statement (quarterly, 2026-03-31) — Net Income: 29600000.00
MDA.TO income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 29600000.00
MDA.TO income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 29600000.00
MDA.TO income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 29600000.00
MDA.TO income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 29600000.00
MDA.TO cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 29600000.00
MDA.TO income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 29600000.00
MDA.TO cash_flow (quarterly, 2026-03-31) — Net Intangibles Purchase And Sale: -21300000.00
MDA.TO income_statement (quarterly, 2026-03-31) — Net Interest Income: -5400000.00
MDA.TO cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: 9400000.00
MDA.TO cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -33000000.00
MDA.TO cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: -33000000.00
MDA.TO income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -5400000.00
MDA.TO balance_sheet (quarterly, 2026-03-31) — Net PPE: 777100000.00
MDA.TO cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -67200000.00
MDA.TO balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 169100000.00
MDA.TO balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Assets: 15400000.00
MDA.TO balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 233700000.00
MDA.TO balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 15400000.00
MDA.TO balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 233700000.00
MDA.TO income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 70100000.00
MDA.TO income_statement (quarterly, 2026-03-31) — Normalized Income: 23852427.18
MDA.TO cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 60900000.00
MDA.TO cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: 1900000.00
MDA.TO income_statement (quarterly, 2026-03-31) — Operating Income: 40100000.00
MDA.TO income_statement (quarterly, 2026-03-31) — Operating Revenue: 464100000.00
MDA.TO balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 138659395.00
MDA.TO cash_flow (quarterly, 2026-03-31) — Other Cash Adjustment Outside Changein Cash: 2700000.00
MDA.TO balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 46700000.00
MDA.TO balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 19800000.00
MDA.TO balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: 30100000.00
MDA.TO income_statement (quarterly, 2026-03-31) — Other Gand A: 18400000.00
MDA.TO income_statement (quarterly, 2026-03-31) — Other Income Expense: 6500000.00
MDA.TO balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 872700000.00
MDA.TO cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 5700000.00
MDA.TO balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 275900000.00
MDA.TO balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 23300000.00
MDA.TO balance_sheet (quarterly, 2026-03-31) — Other Payable: 86800000.00
MDA.TO balance_sheet (quarterly, 2026-03-31) — Other Properties: 100700000.00
MDA.TO balance_sheet (quarterly, 2026-03-31) — Other Receivables: 207400000.00
MDA.TO balance_sheet (quarterly, 2026-03-31) — Payables: 558200000.00
MDA.TO balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 558200000.00
MDA.TO income_statement (quarterly, 2026-03-31) — Pretax Income: 41200000.00
MDA.TO cash_flow (quarterly, 2026-03-31) — Proceeds From Stock Option Exercised: 2900000.00
MDA.TO balance_sheet (quarterly, 2026-03-31) — Properties: 0.00
MDA.TO cash_flow (quarterly, 2026-03-31) — Purchase Of Intangibles: -21300000.00
MDA.TO cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -67200000.00
MDA.TO balance_sheet (quarterly, 2026-03-31) — Raw Materials: 17400000.00
MDA.TO balance_sheet (quarterly, 2026-03-31) — Receivables: 412800000.00
MDA.TO income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 348900000.00
MDA.TO income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 30500000.00
MDA.TO cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -128000000.00
MDA.TO income_statement (quarterly, 2026-03-31) — Research And Development: 8600000.00
MDA.TO balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 276800000.00
MDA.TO income_statement (quarterly, 2026-03-31) — Salaries And Wages: 5800000.00
MDA.TO cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 9400000.00
MDA.TO income_statement (quarterly, 2026-03-31) — Selling And Marketing Expense: 11800000.00
MDA.TO income_statement (quarterly, 2026-03-31) — Selling General And Administration: 36000000.00
MDA.TO balance_sheet (quarterly, 2026-03-31) — Share Issued: 138659395.00
MDA.TO cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 4300000.00
MDA.TO balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 1846700000.00
MDA.TO balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 169100000.00
MDA.TO income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 2252427.18
MDA.TO income_statement (quarterly, 2026-03-31) — Tax Provision: 11600000.00
MDA.TO income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.28
MDA.TO balance_sheet (quarterly, 2026-03-31) — Taxes Receivable: 56400000.00
MDA.TO cash_flow (quarterly, 2026-03-31) — Taxes Refund Paid: -4100000.00
MDA.TO balance_sheet (quarterly, 2026-03-31) — Total Assets: 3796300000.00
MDA.TO balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 2091400000.00
MDA.TO balance_sheet (quarterly, 2026-03-31) — Total Debt: 380700000.00
MDA.TO balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 1846700000.00
MDA.TO income_statement (quarterly, 2026-03-31) — Total Expenses: 424000000.00
MDA.TO balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 1949600000.00
MDA.TO balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 2755800000.00
MDA.TO balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 641100000.00
MDA.TO income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: 40100000.00
MDA.TO balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 12800000.00
MDA.TO income_statement (quarterly, 2026-03-31) — Total Unusual Items: 8000000.00
MDA.TO income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 8000000.00
MDA.TO balance_sheet (quarterly, 2026-03-31) — Tradeand Other Payables Non Current: 23200000.00
MDA.TO balance_sheet (quarterly, 2026-03-31) — Work In Process: 16900000.00
MDA.TO balance_sheet (quarterly, 2026-03-31) — Working Capital: -268000000.00
MDAI cash_flow (annual, 2021-12-31) — Capital Expenditure: -7000.00
MDAI cash_flow (annual, 2021-12-31) — Cash Flow From Continuing Investing Activities: -7000.00
MDAI balance_sheet (annual, 2021-12-31) — Current Provisions: 957000.00
MDAI balance_sheet (annual, 2021-12-31) — Income Tax Payable: 0.00
MDAI balance_sheet (annual, 2021-12-31) — Interest Payable: 11000.00
MDAI cash_flow (annual, 2021-12-31) — Investing Cash Flow: -7000.00
MDAI cash_flow (annual, 2021-12-31) — Net PPE Purchase And Sale: -7000.00
MDAI cash_flow (annual, 2021-12-31) — Net Short Term Debt Issuance: -701000.00
MDAI balance_sheet (annual, 2021-12-31) — Other Non Current Assets: 40000.00
MDAI balance_sheet (annual, 2021-12-31) — Other Receivables: 71000.00
MDAI income_statement (annual, 2021-12-31) — Preferred Stock Dividends: 1259000.00
MDAI cash_flow (annual, 2021-12-31) — Purchase Of PPE: -7000.00
MDAI cash_flow (annual, 2021-12-31) — Short Term Debt Payments: -701000.00
MDAI income_statement (annual, 2021-12-31) — Total Other Finance Cost: 17000.00
MDAI income_statement (annual, 2022-12-31) — +Operating Expense: 13484000.00
MDAI income_statement (annual, 2022-12-31) — +Total Revenue: 25368000.00
MDAI balance_sheet (annual, 2022-12-31) — Accounts Payable: 2759000.00
MDAI balance_sheet (annual, 2022-12-31) — Accounts Receivable: 2294000.00
MDAI balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 23929000.00
MDAI income_statement (annual, 2022-12-31) — Basic Average Shares: 15688268.00
MDAI income_statement (annual, 2022-12-31) — Basic EPS: -0.19
MDAI cash_flow (annual, 2022-12-31) — Beginning Cash Position: 16121000.00
MDAI balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 1026000.00
MDAI balance_sheet (annual, 2022-12-31) — Capital Stock: 1000.00
MDAI balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 14174000.00
MDAI balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 14174000.00
MDAI balance_sheet (annual, 2022-12-31) — Cash Financial: 14174000.00
MDAI cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: -785000.00
MDAI cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: 0.00
MDAI cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: -1162000.00
MDAI cash_flow (annual, 2022-12-31) — Change In Account Payable: 1345000.00
MDAI cash_flow (annual, 2022-12-31) — Change In Accrued Expense: 51000.00
MDAI cash_flow (annual, 2022-12-31) — Change In Inventory: 0.00
MDAI cash_flow (annual, 2022-12-31) — Change In Other Current Assets: 40000.00
MDAI cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: -561000.00
MDAI cash_flow (annual, 2022-12-31) — Change In Payable: 1345000.00
MDAI cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 1396000.00
MDAI cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: 615000.00
MDAI cash_flow (annual, 2022-12-31) — Change In Receivables: -1406000.00
MDAI cash_flow (annual, 2022-12-31) — Change In Working Capital: 84000.00
MDAI cash_flow (annual, 2022-12-31) — Changes In Account Receivables: -859000.00
MDAI cash_flow (annual, 2022-12-31) — Changes In Cash: -1947000.00
MDAI balance_sheet (annual, 2022-12-31) — Common Stock: 1000.00
MDAI balance_sheet (annual, 2022-12-31) — Common Stock Equity: 11996000.00
MDAI cash_flow (annual, 2022-12-31) — Common Stock Issuance: 0.00
MDAI income_statement (annual, 2022-12-31) — Cost Of Revenue: 14531000.00
MDAI balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 1871000.00
MDAI balance_sheet (annual, 2022-12-31) — Current Assets: 17687000.00
MDAI balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 680000.00
MDAI balance_sheet (annual, 2022-12-31) — Current Debt: 175000.00
MDAI balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 855000.00
MDAI balance_sheet (annual, 2022-12-31) — Current Deferred Assets: 0.00
MDAI balance_sheet (annual, 2022-12-31) — Current Deferred Liabilities: 0.00
MDAI balance_sheet (annual, 2022-12-31) — Current Deferred Revenue: 0.00
MDAI balance_sheet (annual, 2022-12-31) — Current Liabilities: 6374000.00
MDAI balance_sheet (annual, 2022-12-31) — Current Notes Payable: 175000.00
MDAI balance_sheet (annual, 2022-12-31) — Current Provisions: 736000.00
MDAI cash_flow (annual, 2022-12-31) — Depreciation: 568000.00
MDAI cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 568000.00
MDAI cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 568000.00
MDAI income_statement (annual, 2022-12-31) — Diluted Average Shares: 15688268.00
MDAI income_statement (annual, 2022-12-31) — Diluted EPS: -0.19
MDAI income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -2912000.00
MDAI income_statement (annual, 2022-12-31) — EBIT: -2647000.00
MDAI income_statement (annual, 2022-12-31) — EBITDA: -2079000.00
MDAI cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: 0.00
MDAI cash_flow (annual, 2022-12-31) — End Cash Position: 14174000.00
MDAI cash_flow (annual, 2022-12-31) — Financing Cash Flow: -785000.00
MDAI cash_flow (annual, 2022-12-31) — Free Cash Flow: -1162000.00
MDAI cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: -57000.00
MDAI income_statement (annual, 2022-12-31) — Gain On Sale Of Security: -180000.00
MDAI balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: 0.00
MDAI income_statement (annual, 2022-12-31) — General And Administrative Expense: 13484000.00
MDAI balance_sheet (annual, 2022-12-31) — Gross PPE: 1029000.00
MDAI income_statement (annual, 2022-12-31) — Gross Profit: 10837000.00
MDAI cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 53000.00
MDAI balance_sheet (annual, 2022-12-31) — Income Tax Payable: 0.00
MDAI income_statement (annual, 2022-12-31) — Interest Income: 21000.00
MDAI income_statement (annual, 2022-12-31) — Interest Income Non Operating: 21000.00
MDAI cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 23000.00
MDAI balance_sheet (annual, 2022-12-31) — Interest Payable: 0.00
MDAI balance_sheet (annual, 2022-12-31) — Inventory: 0.00
MDAI balance_sheet (annual, 2022-12-31) — Invested Capital: 12171000.00
MDAI cash_flow (annual, 2022-12-31) — Investing Cash Flow: 0.00
MDAI cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 0.00
MDAI balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 346000.00
MDAI balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 346000.00
MDAI cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -785000.00
MDAI cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 0.00
MDAI income_statement (annual, 2022-12-31) — Net Income: -2912000.00
MDAI income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -2912000.00
MDAI income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -2912000.00
MDAI income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -2912000.00
MDAI income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -2912000.00
MDAI cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -2912000.00
MDAI income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -2912000.00
MDAI income_statement (annual, 2022-12-31) — Net Interest Income: 21000.00
MDAI cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: -785000.00
MDAI cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: -785000.00
MDAI income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: 21000.00
MDAI balance_sheet (annual, 2022-12-31) — Net PPE: 1029000.00
MDAI cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: 0.00
MDAI cash_flow (annual, 2022-12-31) — Net Short Term Debt Issuance: -785000.00
MDAI balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 11996000.00
MDAI income_statement (annual, 2022-12-31) — Normalized EBITDA: -1899000.00
MDAI income_statement (annual, 2022-12-31) — Normalized Income: -2769800.00
MDAI cash_flow (annual, 2022-12-31) — Operating Cash Flow: -1162000.00
MDAI cash_flow (annual, 2022-12-31) — Operating Gains Losses: -57000.00
MDAI income_statement (annual, 2022-12-31) — Operating Income: -2647000.00
MDAI income_statement (annual, 2022-12-31) — Operating Revenue: 25368000.00
MDAI balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 15688268.00
MDAI balance_sheet (annual, 2022-12-31) — Other Current Assets: 270000.00
MDAI balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 129000.00
MDAI income_statement (annual, 2022-12-31) — Other Gand A: 13484000.00
MDAI income_statement (annual, 2022-12-31) — Other Income Expense: -180000.00
MDAI income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: 49000.00
MDAI balance_sheet (annual, 2022-12-31) — Other Properties: 1029000.00
MDAI balance_sheet (annual, 2022-12-31) — Other Receivables: 618000.00
MDAI balance_sheet (annual, 2022-12-31) — Payables: 2869000.00
MDAI balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 4740000.00
MDAI balance_sheet (annual, 2022-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 650000.00
MDAI balance_sheet (annual, 2022-12-31) — Preferred Stock: 0.00
MDAI balance_sheet (annual, 2022-12-31) — Prepaid Assets: 331000.00
MDAI income_statement (annual, 2022-12-31) — Pretax Income: -2806000.00
MDAI cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 0.00
MDAI cash_flow (annual, 2022-12-31) — Purchase Of PPE: 0.00
MDAI balance_sheet (annual, 2022-12-31) — Receivables: 2912000.00
MDAI income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 14531000.00
MDAI income_statement (annual, 2022-12-31) — Reconciled Depreciation: 568000.00
MDAI cash_flow (annual, 2022-12-31) — Repayment Of Debt: -785000.00
MDAI income_statement (annual, 2022-12-31) — Restructuring And Mergern Acquisition: 0.00
MDAI balance_sheet (annual, 2022-12-31) — Retained Earnings: -11934000.00
MDAI income_statement (annual, 2022-12-31) — Selling General And Administration: 13484000.00
MDAI balance_sheet (annual, 2022-12-31) — Share Issued: 15688268.00
MDAI cash_flow (annual, 2022-12-31) — Short Term Debt Payments: -785000.00
MDAI income_statement (annual, 2022-12-31) — Special Income Charges: 0.00
MDAI cash_flow (annual, 2022-12-31) — Stock Based Compensation: 1155000.00
MDAI balance_sheet (annual, 2022-12-31) — Stockholders Equity: 11996000.00
MDAI balance_sheet (annual, 2022-12-31) — Tangible Book Value: 11996000.00
MDAI income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: -37800.00
MDAI income_statement (annual, 2022-12-31) — Tax Provision: 106000.00
MDAI income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.21
MDAI balance_sheet (annual, 2022-12-31) — Total Assets: 18716000.00
MDAI balance_sheet (annual, 2022-12-31) — Total Capitalization: 11996000.00
MDAI balance_sheet (annual, 2022-12-31) — Total Debt: 1201000.00
MDAI balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 11996000.00
MDAI income_statement (annual, 2022-12-31) — Total Expenses: 28015000.00
MDAI balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 6720000.00
MDAI balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 1029000.00
MDAI balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 346000.00
MDAI income_statement (annual, 2022-12-31) — Total Operating Income As Reported: -2647000.00
MDAI income_statement (annual, 2022-12-31) — Total Other Finance Cost: 12000.00
MDAI balance_sheet (annual, 2022-12-31) — Total Tax Payable: 110000.00
MDAI income_statement (annual, 2022-12-31) — Total Unusual Items: -180000.00
MDAI income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -180000.00
MDAI balance_sheet (annual, 2022-12-31) — Working Capital: 11313000.00
MDAI income_statement (annual, 2023-12-31) — +Operating Expense: 20864000.00
MDAI income_statement (annual, 2023-12-31) — +Total Revenue: 18056000.00
MDAI balance_sheet (annual, 2023-12-31) — Accounts Payable: 2683000.00
MDAI balance_sheet (annual, 2023-12-31) — Accounts Receivable: 2346000.00
MDAI balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 31065000.00
MDAI income_statement (annual, 2023-12-31) — Basic Average Shares: 14087586.00
MDAI income_statement (annual, 2023-12-31) — Basic EPS: -1.48
MDAI cash_flow (annual, 2023-12-31) — Beginning Cash Position: 14174000.00
MDAI balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 853000.00
MDAI balance_sheet (annual, 2023-12-31) — Capital Stock: 2000.00
MDAI balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 4790000.00
MDAI balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 4790000.00
MDAI balance_sheet (annual, 2023-12-31) — Cash Financial: 4790000.00
MDAI cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 3844000.00
MDAI cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: -13240000.00
MDAI cash_flow (annual, 2023-12-31) — Change In Account Payable: -935000.00
MDAI cash_flow (annual, 2023-12-31) — Change In Accrued Expense: 1359000.00
MDAI cash_flow (annual, 2023-12-31) — Change In Inventory: -230000.00
MDAI cash_flow (annual, 2023-12-31) — Change In Other Current Assets: -404000.00
MDAI cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: -656000.00
MDAI cash_flow (annual, 2023-12-31) — Change In Other Working Capital: 2311000.00
MDAI cash_flow (annual, 2023-12-31) — Change In Payable: -935000.00
MDAI cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: 424000.00
MDAI cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: -377000.00
MDAI cash_flow (annual, 2023-12-31) — Change In Receivables: 566000.00
MDAI cash_flow (annual, 2023-12-31) — Change In Working Capital: 1634000.00
MDAI cash_flow (annual, 2023-12-31) — Changes In Account Receivables: -52000.00
MDAI cash_flow (annual, 2023-12-31) — Changes In Cash: -9396000.00
MDAI balance_sheet (annual, 2023-12-31) — Common Stock: 2000.00
MDAI balance_sheet (annual, 2023-12-31) — Common Stock Equity: -1709000.00
MDAI cash_flow (annual, 2023-12-31) — Common Stock Issuance: 3351000.00
MDAI income_statement (annual, 2023-12-31) — Cost Of Revenue: 10176000.00
MDAI balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 3473000.00
MDAI balance_sheet (annual, 2023-12-31) — Current Assets: 9902000.00
MDAI balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 853000.00
MDAI balance_sheet (annual, 2023-12-31) — Current Debt: 436000.00
MDAI balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 1289000.00
MDAI balance_sheet (annual, 2023-12-31) — Current Deferred Assets: 283000.00
MDAI balance_sheet (annual, 2023-12-31) — Current Deferred Liabilities: 2311000.00
MDAI balance_sheet (annual, 2023-12-31) — Current Deferred Revenue: 2311000.00
MDAI balance_sheet (annual, 2023-12-31) — Current Liabilities: 12401000.00
MDAI balance_sheet (annual, 2023-12-31) — Current Notes Payable: 436000.00
MDAI cash_flow (annual, 2023-12-31) — Depreciation: 722000.00
MDAI cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 722000.00
MDAI cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 722000.00
MDAI income_statement (annual, 2023-12-31) — Diluted Average Shares: 14087586.00
MDAI income_statement (annual, 2023-12-31) — Diluted EPS: -1.48
MDAI income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -20854000.00
MDAI income_statement (annual, 2023-12-31) — EBIT: -20843000.00
MDAI income_statement (annual, 2023-12-31) — EBITDA: -20121000.00
MDAI cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: 12000.00
MDAI cash_flow (annual, 2023-12-31) — End Cash Position: 4790000.00
MDAI cash_flow (annual, 2023-12-31) — Financing Cash Flow: 3844000.00
MDAI cash_flow (annual, 2023-12-31) — Free Cash Flow: -13240000.00
MDAI cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: -335000.00
MDAI income_statement (annual, 2023-12-31) — Gain On Sale Of Security: 311000.00
MDAI balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: 12000.00
MDAI income_statement (annual, 2023-12-31) — General And Administrative Expense: 20864000.00
MDAI balance_sheet (annual, 2023-12-31) — Gross PPE: 790000.00
MDAI income_statement (annual, 2023-12-31) — Gross Profit: 7880000.00
MDAI cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 114000.00
MDAI income_statement (annual, 2023-12-31) — Interest Expense: 0.00
MDAI income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 0.00
MDAI income_statement (annual, 2023-12-31) — Interest Income: 172000.00
MDAI income_statement (annual, 2023-12-31) — Interest Income Non Operating: 172000.00
MDAI cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 29000.00
MDAI balance_sheet (annual, 2023-12-31) — Inventory: 230000.00
MDAI balance_sheet (annual, 2023-12-31) — Invested Capital: -1273000.00
MDAI cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 3351000.00
MDAI cash_flow (annual, 2023-12-31) — Issuance Of Debt: 0.00
MDAI balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 0.00
MDAI balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 0.00
MDAI cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 0.00
MDAI cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -483000.00
MDAI cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 3351000.00
MDAI income_statement (annual, 2023-12-31) — Net Income: -20854000.00
MDAI income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -20854000.00
MDAI income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -20854000.00
MDAI income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -20854000.00
MDAI income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -20854000.00
MDAI cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -20854000.00
MDAI income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -20854000.00
MDAI income_statement (annual, 2023-12-31) — Net Interest Income: 172000.00
MDAI cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: -483000.00
MDAI cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: -483000.00